Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 4Phase 2/3 2Phase 1/2 2Phase NA 1Phase 4 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Sezary Syndrome 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 25Blood Specimen Collection 20Radiotherapy 19Surveys and Questionnaires 18Exercise 17Early Intervention, Educational 17Methods 16Standard of Care 15Cyclophosphamide 15Surgical Procedures, Operative 14Radiotherapy, Intensity-Modulated 14Biopsy 13Acupuncture Therapy 12Interviews as Topic 11Educational Status 11Cisplatin 11Filgrastim 10Radiofrequency Ablation 9Magnetic Resonance Imaging 9Fluorodeoxyglucose F18 9fludarabine phosphate 8Radiation 8Practice Guidelines as Topic 8Gemcitabine 8X-Rays 7Sorafenib 7Granulocyte Colony-Stimulating Factor 7Colonoscopy 7Capecitabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Terminated × peginterferon alfa-2b × Clear all
NCT00724061 2018-12-12

Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL

Northwestern University

Phase NA Terminated
7 enrolled 5 charts
DermatologicLymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡